arrow
Back
M

Michele Maio

university of siena and university hospital of siena

99H-index
843Paper Count
8.4WCitation Count
Published Papers 195
Publication Date
Transposable elements and homotypic niches drive immune dynamics and resistance in melanoma epigenetic-based immunotherapy
err2026-08-07
err0
errOAAI
errErika Ciervo; Francesco Ceccarelli; Anna Maria Di Giacomo; Piera Grisolia; Alessia Covre; Zein Mersini Besharat; Antonio De Falco; Francesca Pia Caruso; Luigi Laezza; Luigi Ferraro; Gloria Mas Martin; Daniel Bilbao; Sion Williams; Benjamin Currall; Maria Fortunata Lofiego; Tommaso Sani; Elisabetta Ferretti; Yan Guo; Sean B. Holden; Ines Simeone; Roberta Mortarini; Andrea Anichini; Michele Maio; Teresa Maria Rosaria Noviello; Michele Ceccarelli
errShare
errSave
Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanoma
err2026-05-08
err0
errOAAI
errElena Splendiani; Zein Mersini Besharat; Claudia Sabato; Teresa Maria Rosaria Noviello; Maria Fortunata Lofiego; Vincenzo D’Alonzo; Monica Valente; Laura Solmonese; Alessia Covre; Sandra Coral; Francesca Pia Caruso; Tanja Milena Autilio; Ines Simeone; Agnese Po; Anna Citarella; Giuseppina Catanzaro; Roberta Mortarini; Andrea Anichini; Michele Maio; Michele Ceccarelli; Anna Maria Di Giacomo; Elisabetta Ferretti
errShare
errSave
Retreatment, rechallenge, and escalation with subsequent immune checkpoint inhibitor therapies across cancers after initial failure
err2025-11-06
err0
errOAAI
errI.P. da Silva; L. Zimmer; J.-Y. Blay; M. Maio; J. Larkin; M.-O. Grimm; S. Puri; M.O. Butler; S. Patel; P.K. Thakkar; G.V. Long; I. Melero
errShare
errSave
The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets
err2025-09-10
err0
errOAAI
errLaura Solmonese; Maria Fortunata Lofiego; Carolina Fazio; Francesco Marzani; Francesca Piazzini; Emma Bello; Fabrizio Celesti; Gianluca Giacobini; Xiaohui Wang; Michele Maio; Sandra Coral; Anna Maria Di Giacomo; Alessia Covre
errShare
errSave
Neoadjuvant Intralesional Targeted Immunocytokines (Daromun) in Stage III Melanoma.
err2025-07-07
err0
PREAI
errK.C. Kähler; J.C. Hassel; M. Ziemer; P. Rutkowski; F. Meier; L. Flatz; C. Gaudy-Marqueste; L. Zimmer; M. Santinami; F. Russano; I. von Wasielewski; T.K. Eigentler; M. Maio; I. Zalaudek; S. Haferkamp; P. Quaglino; J. Welzel; C. Röcken; A. Enk; J.-C. Simon; T. Świtaj; M. Garzarolli; T. Amaral; N. Malissen; E. Livingstone; G. Elia; A. Covelli; K. Lorizzo; D. Neri; S. Mulatto; A. Parca; B. Pizzichi; P.A. Ascierto; C. Garbe; C. Robert; D. Schadendorf; A. Hauschild
errShare
errSave
Approaches to overcome the current treatment plateau in immunotherapy
err2025-07-06
err0
PREAI
errAnna Maria Di Giacomo; Renzo Canetta; John Connolly; Rom Leidner; Wei Zheng; Young Kim; Ramy Ibrahim; Michael Lahn; Michael Smith; Alexander Eggermont; Bernard A. Fox; Michele Maio
errShare
errSave
Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial
err2025-02-20
err0
PREAI
errMarabelle, Aurelien; O'Malley, David M.; Hendifar, Andrew E.; Ascierto, Paolo A.; Motola-Kuba, Daniel; Penel, Nicolas; Cassier, Philippe A.; Bariani, Giovanni; De Jesus-Acosta, Ana; Doi, Toshihiko; Longo, Federico; Miller, Wilson H.; Oh, Do-Youn; Gottfried, Maya; Yao, Lili; Jin, Fan; Gozman, Alexander; Maio, Michele
errShare
errSave
DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy
err2025-02-18
err0
errOAAI
errLofiego, Maria Fortunata; Tufano, Rossella; Bello, Emma; Solmonese, Laura; Marzani, Francesco; Piazzini, Francesca; Celesti, Fabrizio; Caruso, Francesca Pia; Noviello, Teresa Maria Rosaria; Mortarini, Roberta; Anichini, Andrea; Ceccarelli, Michele; Calabro, Luana; Maio, Michele; Coral, Sandra; Di Giacomo, Anna Maria; Covre, Alessia; EPigenetic Immune-Oncology Consortium Airc EPICA Investigators
errShare
errSave
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results
err2025-02-01
err2
PREAI
errO'Malley, David M.; Bariani, Giovani M.; Cassier, Philippe A.; Marabelle, Aurelien; Hansen, Aaron R.; Acosta, Ana De Jesus; Miller Jr, Wilson H.; Safra, Tamar; Italiano, Antoine; Mileshkin, Linda; Yao, Lili; Gozma, Alexander; Jin, Fan; Maio, Michele
errShare
errSave
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study
err2024-10-08
err0
errOAAI
errMortier, Laurent; Villabona, Lisa; Lawrence, Ben; Arance, Ana; Butler, Marcus O.; Beylot-Barry, Marie; Saiag, Philippe; Samimi, Mahtab; Ascierto, Paolo A.; Spada, Francesca; De Pontville, Michel; Maio, Michele; Berrocal, Alfonso; Espinosa, Enrique; Capdevila, Jaume; Levin, Max; Das, Debasmita; Krepler, Clemens; Grebennik, Dmitri; Chiarion-Sileni, Vanna
errShare
errSave
Emerging role of HOXB9 transcription factor in cutaneous melanoma
err2024-10-01
err0
PREAI
errMontico, B.; Bellazzo, A.; Salvati, A.; Guerrieri, R.; Colizzi, F.; Nassa, G.; Lamberti, J.; Weisz, A.; Covre, A.; Maio, M.; Steffan, A.; Fratta, E.
errShare
errSave
Nivolumab plus relatlimab vs nivolumab in previously untreated metastatic or unresectable melanoma: 3-year subgroup analyses from RELATIVITY-047
err2024-09-01
err0
PREAI
errSchadendorf, D.; Tawbi, H. A.; Hodi, F. S.; Lipson, E. J.; Ascierto, P. A.; Medina Soto, F. A.; Maio, M.; Hernberg, M.; Mackiewicz, J.; Prey, S.; Mujika Eizmendi, M. K.; Atkinson, V. G.; Hassel, J. C.; Cinat, G.; Keidel, S.; Rodriguez, S.; Wang, P. T.; Dolfi, S.; Long, G. V.
errShare
errSave
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial (vol 199, 113531, 2024)
err2024-05-01
err0
PREAI
errDi Giacomo, Anna Maria; Chiarion-Sileni, Vanna; Del Vecchio, Michele; Ferrucci, Pier Francesco; Guida, Michele; Quaglino, Pietro; Guidoboni, Massimo; Marchetti, Paolo; Simonetti, Elena; Santangelo, Federica; Amato, Giovanni; Covre, Alessia; Camerini, Roberto; Valente, Monica; Mandala, Mario; Giannarelli, Diana; Calabro, Luana; Maio, Michele
errShare
errSave
Improving Influenza Vaccination Coverage in Patients with Cancer: A Position Paper from a Multidisciplinary Expert Group
err2024-04-16
err0
errOAAI
errBonanni, Paolo; Maio, Michele; Beretta, Giordano D.; Icardi, Giancarlo; Rossi, Alessandro; Cinieri, Saverio
errShare
errSave
Results from KEYNOTE-B99: Phase 2 study of first-line (1L) pembrolizumab (pembro) plus investigational agents and chemotherapy (chemo) for extensive-stage small-cell lung cancer (ES-SCLC)
err2024-04-05
err0
PREAI
errRodriguez-Abreu, Delvys; Hochmair, Maximillian; Cho, Byoung Chul; Csoszi, Tibor; Kutiel, Talia Shentzer; Mueller, Veronika; Ahn, Myung-Ju; Kowalski, Dariusz; Maio, Michele; Moiseyenko, Vladimir; Navarro, Alejandro; Niu, Jianxin; Fung, Andrea S.; Lips, Carolin; Zhou, Heng; Zhao, Bin; Lara-Guerra, Humberto; Peled, Nir
errShare
errSave
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?
err2024-04-01
err8
errOAAI
errSplendiani, Elena; Besharat, Zein Mersini; Covre, Alessia; Maio, Michele; Di Giacomo, Anna Maria; Ferretti, Elisabetta
errShare
errSave
A new paradigm for brain tumors treatment: Guadecitabine as a fundamental player to improve tumor immune response
err2024-03-22
err0
PREAI
errLofiego, Maria Fortunata; Piazzini, Francesca; Caruso, Francesca Pia; Marzani, Francesco; Solmonese, Laura; Bello, Emma; Celesti, Fabrizio; Costa, Maria Claudia; Noviello, Teresa Maria; Mortarini, Roberta; Anichini, Andrea; Ceccarelli, Michele; Coral, Sandra; Di Giacomo, Anna Maria; Maio, Michele; Covre, Alessia
errShare
errSave
Spry1 targeting enhances E-cadherin expression in cutaneous melanoma
err2024-03-22
err0
PREAI
errMontico, Barbara; Giurato, Giorgio; Guerrieri, Roberto; Salvati, Annamaria; Colizzi, Francesca; Baboci, Lorena; Sigalotti, Luca; Covre, Alessia; Maio, Michele; Steffan, Agostino; Nyman, Tuula Anneli; Weisz, Alessandro; Mongiat, Maurizio; Andreuzzi, Eva; Fratta, Elisabetta
errShare
errSave
Immunotherapy in cutaneous melanoma and biologics in psoriatic disease: similarities and differences from a clinical multidisciplinary perspective
err2024-03-03
err2
PREAI
errRoccuzzo, Gabriele; Gherardi, Eleonora; Maio, Michele; Malagoli, Piergiorgio; Marzano, Angelo Valerio; Parodi, Aurora; Pimpinelli, Nicola; Spagnolo, Francesco; Di Giacomo, Anna Maria; Quaglino, Pietro
errShare
errSave
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial
err2024-03-01
err7
errOAAI
errDi Giacomo, Anna Maria; Chiarion-Sileni, Vanna; Del Vecchio, Michele; Ferrucci, Pier Francesco; Guida, Michele; Quaglino, Pietro; Guidoboni, Massimo; Marchetti, Paolo; Simonetti, Elena; Santangelo, Federica; Amato, Giovanni; Covre, Alessia; Camerini, Roberto; Valente, Monica; Mandala, Mario; Giannarelli, Diana; Calabro, Luana; Maio, Michele
errShare
errSave